Target intelligence / Profile preview

Cardioplegia

Molecular classification
Other
01

Overview

Cardioplegia is the intentional and temporary arrest of cardiac function induced by chemical solutions, primarily used to protect the heart muscle during open-heart surgery by minimizing tissue injury during periods of no blood flow. The technique typically uses cold, potassium-rich solutions (sometimes with other additives like magnesium, lidocaine, or blood) perfused into the coronary circulation, causing electrical and mechanical cardiac arrest. This provides a bloodless and motionless surgical field and reduces metabolic requirements, helping to prevent myocardial ischemia and reperfusion injury. Cardioplegia is a procedural strategy, not a molecular target or receptor.

Other names
cardioplegic solutioncardioplegic arrestcardiac arrest solution
02

Mechanism of action

Induced diastolic arrest via membrane depolarization (usually potassium-rich solution causes cardiac myocyte electrical arrest), hypothermia (to lower metabolic demand), and/or additional pharmacologic protection (e.g., lidocaine, magnesium)

03

Biological functions

Other
04

Disease associations

Cardiovascular disease
05

Safety considerations

Reversible myocardial depressionElectrolyte imbalanceRisk of inadequate myocardial protection leading to ischemia-reperfusion injuryHemodilutionArrhythmia after reperfusion
06

Interacting drugs

Custodiol (HTK)

5 more in the full profile.

07

Biomarkers

Cardiac troponin I (cTnI)Cardiac troponin T (cTnT)Creatine kinase-MB (CK-MB)

Beyond the preview

Go deeper on Cardioplegia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardioplegia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call